Top Wall Street Stories: Research Frontiers Inc. (NASDAQ:REFR), Ocera Therapeutics, Inc. (NASDAQ:OCRX), Square 1 Financial, Inc. (NASDAQ:SQBK), Neuralstem, Inc. (NASDAQ:CUR)

Research Frontiers Inc. (NASDAQ:REFR) said that, it will host a conference call to discuss results of operations for the second quarter of 2015 as well as recent developments on 6 August. Research Frontiers Inc. (NASDAQ:REFR) belongs to Industrial Goods sector. Its weekly performance is 10.98%. On last trading day company shares ended up $5.66. Research Frontiers Inc. (NASDAQ:REFR) distance from 50-day simple moving average (SMA50) is 1.52%.

On 3 August, Ocera Therapeutics, Inc. (NASDAQ:OCRX) announced recent business highlights and reported financial results for the quarter ended June 30, 2015. Research and development (R&D) expense for three months ended June 30, 2015 was $3.4 million, compared to $4.8 million for the same period in 2014. R&D expense for the six months ended June 30, 2015 was $7.8 million, compared to $7.3 million for the same period in 2014.Ocera Therapeutics, Inc. (NASDAQ:OCRX) shares increased 9.26% in last trading session and ended the day at $4.13. OCRX return on assets is -52.50%. Ocera Therapeutics, Inc. (NASDAQ:OCRX) quarterly performance is 16.01%.

Square 1 Financial, Inc. (NASDAQ:SQBK) announced that it has provided a $1.5 million credit facility to new client Azalea Health, a leading cloud-based healthcare IT provider focused on patient engagement and practice management efficiency. Proceeds will be used to support the company’s continued growth. Square 1 Financial, Inc. (NASDAQ:SQBK) ended the last trading day at $27.07. Company weekly volatility is calculated as 1.12% and price to cash ratio as 6.11. Square 1 Financial, Inc. (NASDAQ:SQBK) showed a weekly performance of 0.22%.

On 22 July, Neuralstem, Inc. (NASDAQ:CUR) has just announced the US District Court in Maryland has decided to dismiss StemCell, Inc.’s previously filed patent infringement case with prejudice in StemCells, Inc. v. Neuralstem, Inc. in favor of Neuralstem. Neuralstem, Inc. (NASDAQ:CUR) shares decreased -3.11% in last trading session and ended the day at $1.56. CUR return on assets is -71.50%. Neuralstem, Inc. (NASDAQ:CUR) quarterly performance is -11.36%.

Leave a Reply

Your email address will not be published. Required fields are marked *